NEWMarkets
Acadia Pharmaceuticals (ACAD) Stock Target Lowered to $33
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has lowered the price target for Acadia Pharmaceuticals (ACAD) to $33. This adjustment reflects changes in market expectations and financial analysis, indicating a revision from previous forecasts. A lower price target can influence investor sentiment and trading behavior. The change may affect how investors approach Acadia's stock moving forward.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
